HOTH (Hoth Therapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings

Hoth Therapeutics, Inc. Common Stock (HOTH) is a publicly traded Healthcare sector company. As of May 21, 2026, HOTH trades at $0.59 with a market cap of $11.72M and a P/E ratio of -0.66. HOTH moved +0.10% today. Year to date, HOTH is -43.41%; over the trailing twelve months it is -29.07%. Its 52-week range spans $0.49 to $3.80. Rallies surfaces HOTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate HOTH?

The average price target is $0.00.

HOTH Key Metrics

Key financial metrics for HOTH
MetricValue
Price$0.59
Market Cap$11.72M
P/E Ratio-0.66
EPS$-0.90
Dividend Yield0.00%
52-Week High$3.80
52-Week Low$0.49
Volume2.40K
Avg Volume0
Revenue (TTM)$0
Net Income$-12.47M
Gross Margin0.00%

HOTH Analyst Consensus

HOTH analyst coverage data. Average price target: $0.00.

Latest HOTH News

Recent HOTH Insider Trades

  • Knie Robb bought 25.00K (~$16.75K) on Aug 16, 2024.
  • Knie Robb bought 10.00K (~$3.90K) on Sep 19, 2022.
  • Knie Robb bought 10.00K (~$4.00K) on Sep 16, 2022.

Common questions about HOTH

What do analysts rate HOTH?
The average price target is $0.00.
Does Rallies show HOTH price targets?
Yes. Rallies tracks HOTH analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is HOTH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HOTH. It does not provide personalized investment advice.
HOTH

HOTH